[Form 4] Acadia Healthcare Company, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Insider sale reported: Nasser Khan, listed as Chief Operating Officer and reporting person for Acadia Healthcare Company, Inc. (ACHC), disposed of 973 shares of common stock on 09/30/2025 at a reported price of $24.54 per share. After the transaction he beneficially owned 55,023 shares in a direct ownership form. The Form 4 was signed by an attorney-in-fact on 10/01/2025.

Insights

Financial Analyst

TL;DR: A routine insider sale of 973 shares by the COO, reducing direct holdings to 55,023 shares; no derivatives reported.

The filing shows a straightforward, single-day disposal of common stock at $24.54 per share. The size of the sale (973 shares) appears small relative to the remaining stake (55,023 shares), indicating this is likely a routine liquidity action rather than a material change in ownership or corporate strategy. No derivative transactions or amendments are reported.

Corporate Governance Expert

TL;DR: Disclosure complies with Section 16 reporting; transaction was documented and signed by an attorney-in-fact.

The Form 4 includes the required details: reporting person identity, relationship (Officer, COO), transaction date, transaction code (F), number sold, price, and post-transaction beneficial ownership. The signature by an attorney-in-fact is noted and dated. There are no indications of other related-party or indirect holdings in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Khan Nasser

(Last) (First) (Middle)

6100 TOWER CIRCLE, SUITE 1000

(Street)

FRANKLIN TN 37067

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Acadia Healthcare Company, Inc. [ ACHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/30/2025		F		973	D	$24.54	55,023	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Brian Farley as Attorney in Fact for Nasser Khan	10/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did ACHC COO Nasser Khan report on Form 4?

Nasser Khan reported a sale of 973 shares of Acadia Healthcare common stock on 09/30/2025 at $24.54 per share.

How many ACHC shares does Nasser Khan own after the reported transaction?

55,023 shares beneficially owned following the reported sale, held in a direct ownership form.

What was the transaction code and date on the Form 4 for ACHC (ticker ACHC)?

Transaction code F (disposition) with a transaction date of 09/30/2025.

Was any derivative security activity reported by the reporting person for ACHC?

No derivative securities or option transactions are reported in Table II of this Form 4.

Who signed the Form 4 and when was it signed?

The Form 4 was signed /s/ Brian Farley as Attorney in Fact for Nasser Khan on 10/01/2025.